Ascletis Pharma (1672.HK) Q3 2024 Earnings

30AugConfirmed
Q1 2023
Q1 2024
Q1 2024
Q3 2024
-0.14
-0.09
-0.05
0

Details

Expected EPS
-0.12873635136
Actual EPS
-0.1375333353696
Surprise EPS
-0.01
Surprise Percent
+6.83%

Description

Ascletis Pharma (1672.HK) has reported earnings of -0.1375333353696 per share for Q3 2024.

0 Comments

Share your thoughts